We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
Turnover
18.52%
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
-0.52%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$82.9B
AUM Growth
-$1.95B
(-2.3%)
Cap. Flow
-$950M
Cap. Flow
% of AUM
-1.15%
Top 10 Holdings %
Top 10 Hldgs %
17.78%
Holding
800
New
57
Increased
242
Reduced
371
Closed
71
Avg Time Held
2.5
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$704M |
| 2 |
Howmet Aerospace
HWM
|
+$410M |
| 3 |
Nutrien
NTR
|
+$410M |
| 4 |
American Express
AXP
|
+$381M |
| 5 |
Stellantis
STLA
|
+$351M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$674M |
| 2 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$367M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$365M |
| 4 |
Sanofi
SNY
|
+$364M |
| 5 |
SHPG
Shire pic
SHPG
|
+$363M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.69% |
| 2 | Technology | 15.63% |
| 3 | Industrials | 12.68% |
| 4 | Healthcare | 11.72% |
| 5 | Energy | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
XL
26
DELISTED
XL Group Ltd.
XL
| $704M | 0.85% |
12,747,367
+844,807
| +7% | +$37.1M |
2014 Q1
16 quarters
|
|
27
Everest Group
EG
$14.6B
| $686M | 0.83% |
2,672,684
+932,031
| +54% | +$224M |
2017 Q4
1 quarter
|
|
28
RTX Corp
RTX
$252B
| $680M | 0.82% |
8,584,979
+85,849
| +1% | +$7.09M |
2013 Q2
19 quarters
|
|
29
Delta Air Lines
DAL
$51.4B
| $646M | 0.78% |
11,791,533
+3,306,568
| +39% | +$182M |
2014 Q2
15 quarters
|
|
30
Elevance Health
ELV
$92.9B
| $643M | 0.78% |
2,925,442
-417,364
| -12% | -$98M |
2013 Q2
19 quarters
|
|
|
RDS.A
31
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $641M | 0.77% |
10,045,509
+25,902
| +0.3% | +$1.71M |
2017 Q3
2 quarters
|
|
32
Comcast
CMCSA
$77.3B
| $630M | 0.76% |
18,428,357
+232,276
| +1% | +$9.01M |
2013 Q2
19 quarters
|
|
33
Eaton
ETN
$156B
| $623M | 0.75% |
7,795,802
-1,329,833
| -15% | -$109M |
2015 Q1
12 quarters
|
|
34
Gilead Sciences
GILD
$195B
| $606M | 0.73% |
8,044,702
+272,304
| +4% | +$21.6M |
2014 Q4
13 quarters
|
|
35
Regions Financial
RF
$23.3B
| $605M | 0.73% |
32,541,162
-1,194,930
| -4% | -$22.6M |
2017 Q1
4 quarters
|
|
36
BorgWarner
BWA
$11.9B
| $585M | 0.71% |
13,233,206
+150,829
| +1% | +$7.01M |
2016 Q4
5 quarters
|
|
37
EQT Corp
EQT
$32.8B
| $575M | 0.69% |
22,234,264
+8,481,319
| +62% | +$243M |
2013 Q2
19 quarters
|
|
38
Flex
FLEX
$36.4B
| $569M | 0.69% |
46,244,575
-20,005,035
| -30% | -$273M |
2013 Q2
19 quarters
|
|
39
McKesson
MCK
$116B
| $569M | 0.69% |
4,036,373
+2,221,241
| +122% | +$346M |
2013 Q2
19 quarters
|
|
40
Marathon Petroleum
MPC
$134B
| $563M | 0.68% |
7,698,464
-1,282,955
| -14% | -$88.3M |
2013 Q2
19 quarters
|
|
41
Cummins
CMI
$73.3B
| $549M | 0.66% |
3,384,197
+87,372
| +3% | +$15M |
2017 Q3
2 quarters
|
|
42
DELISTED
WestRock Company
WRK
| $517M | 0.62% |
8,063,026
-583,972
| -7% | -$38.6M |
2015 Q3
10 quarters
|
|
43
KeyCorp
KEY
$21.3B
| $515M | 0.62% |
26,320,920
+275,876
| +1% | +$5.78M |
2017 Q3
2 quarters
|
|
44
DELISTED
TD Ameritrade Holding Corp
AMTD
| $488M | 0.59% |
8,236,689
+4,079,938
| +98% | +$231M |
2013 Q2
19 quarters
|
|
45
ConocoPhillips
COP
$170B
| $487M | 0.59% |
8,213,737
+29,133
| +0.4% | +$1.65M |
2016 Q3
6 quarters
|
|
46
Southwest Airlines
LUV
$20B
| $486M | 0.59% |
8,483,493
+3,914,892
| +86% | +$235M |
2017 Q2
3 quarters
|
|
|
Y
47
DELISTED
Alleghany Corp
Y
| $486M | 0.59% |
790,418
+25,441
| +3% | +$15.3M |
2013 Q2
19 quarters
|
|
48
Cigna
CI
$79B
| $484M | 0.58% |
2,886,546
+186,018
| +7% | +$36.2M |
2015 Q1
12 quarters
|
|
49
Raymond James Financial
RJF
$30.3B
| $463M | 0.56% |
7,770,680
-439,881
| -5% | -$27.4M |
2013 Q2
19 quarters
|
|
50
Huntington Bancshares
HBAN
$31B
| $455M | 0.55% |
30,126,605
-1,305,690
| -4% | -$20.5M |
2013 Q2
19 quarters
|
|
Similar funds
Boston Partners's Q1 2018 Portfolio in Review
As of Q1 2018, Boston Partners held 800 positions worth $82.9B, down 2.3% from $84.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Boston Partners's Q1 2018 filing shows 57 new, 242 increased, 371 reduced and 71 closed positions. Its largest new stake was Nutrien: 8,190,940 shares worth $387M. The largest sale was Apple, an estimated $674M.
By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 29% a quarter earlier, followed by Technology and Industrials.
- Boston Partners's largest Q1 2018 buy was Nutrien: 8,190,940 shares worth $387M.
- Boston Partners added most to Johnson & Johnson in Q1 2018, an estimated $704M increase.
- Boston Partners's biggest Q1 2018 reduction was Apple, cutting an estimated $674M.
- Boston Partners fully exited Sanofi in Q1 2018, selling an estimated $364M.
- Boston Partners's ten largest holdings make up 18% of its $82.9B portfolio in Q1 2018.
- Boston Partners opened 57 new positions and closed 71 in Q1 2018.
- Boston Partners's portfolio value fell 2.3% quarter-over-quarter to $82.9B.
Based on Boston Partners's 13F filing for Q1 2018, filed 4 May 2018.